CLINICAL DIRECTORS NETWORK INC
5 W 37TH ST, NEW YORK, NY 10018 www.cdnetwork.org

Total Revenue
$3,441,017
Total Expenses
$3,381,289
Net Assets
$825,663

Organizations Filed Purposes: THE ORGANIZATION PROMOTES PROFESSIONAL EXCELLENCE AMONG ITS MEMBERSHIP, AND PROVIDES ACCREDITED CONTINUING MEDICAL (CME) DENTAL (CDE) NURSING (CNE), COMMUNITY HEALTH EDUCATION (CHES) AND SOCIAL WORK (CE-SW) EDUCATIONALACTIVITIES, BOTH IN PERSON AND ON-LINE, AS WELL AS CONDUCTING PRACTICE-BASED CLINICAL AND TRANSLATIONAL RESEARCH AND PUBLIC HEALTH PROGRAMS.

PCORI RESEARCH PROJECTS - THE PATIENT - CENTERED OUTCOMES RESEARCH INSTITUTE (PCORI), A 501(C)(1) NONPROFIT CORPORATION IS AN INSTRUMENTALITY OF THE UNITED STATES AND UNDER THE INTERNAL REVENUE CODE IS LISTED AS A GOVERNMENT CORPORATION. GOVERNMENT CORPORATIONS ARE A SEPARATE SET OF CORPORATIONS WHICH OPERATE TO PROVIDE PUBLICSERVICES. DURING 2019, PCORI FUNDED THE FOLLOWING RESEARCH PROGRAMS OPERATED BY CLINICAL DIRECTORS NETWORK, INC.:-COLLABORATIVE CARE TO REDUCE DEPRESSION AND INCREASE CANCER SCREENING AMONG LOW-INCOME URBAN WOMEN.-ENHANCING COMMUNITY HEALTH CENTER BASED PATIENT CENTERED OUTCOMES RESEARCH (ENCORE)-ADDRESSING HIV TREATMENT DISPARITIES USING A SELF-MANAGEMENT PROGRAMINTERACTIVE PERSONAL HEALTH RECORD - GET READY AND EMPOWERED ABOUT TREATMENT (GREAT)-NEW YORK CITY CLINICAL DATA RESEARCH NETWORK (NYC-CDRN).-CHICAGO AREA PATIENT CENTERED CLINICAL OUTCOMES RESEARCH NETWORK.-PATIENT-CENTERED CER STUDY OF HOME-BASED INTERVENTIONS TO PREVENT CA-MRSA INFECTION RE-OCCURANCE.

OTHER RESEARCH PROGRAMS INCLUDE IMPROVING PTSD IN PRIMARY CARE; N2: BUILDING A NETWORK OF SAFETY NET PBRNS; COMMUNITY-ASSOCIATEDMETHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) SURVEILLANCE NETWORKPROJECT; MRSA COMMUNITY ENGAGEMENT AND PILOT RESEARCH PROJECTS AND ACCREDITED CONTINUING MEDICAL, DENTAL, NURSING COMMUNITY HEALTHEDUCATION AND SOCIAL WORK EDUCATIONAL ACTIVITIES;

SYNEOS - ER/LA - EXTENDED RELEASE/LONG ACTING OPIOID POST-MARKETING REQUIREMENT STUDIES TO PROVIDE QUATITATIVE ESTIMATES OF THE SERIOUS RISKS OF MISUSE, ABUSE, ADDICTION, OVERDOSE, AND DEATH ASSOCIATED WITH LONG-TERM USE OF OPIOID ANALGESICS FOR MANAGEMENT OFCHRONIC PAIN, AMONG PATIENTS PRESCRIBED ER/LA OPIOID PRODUCTS.

Executives Listed on Filing

Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing

NameTitleHours Per WeekTotal Salary
Jonathan N Tobin PhdPresident & CEO40$405,306
Andrea N DonaldsonDIRECTOR OF CLINICAL AFFAIRS40$145,626
Liliana LombardiDirector0.5$0
Devin Goodman DmdDirector0.5$0
Walid Michelin Md MphDirector0.5$0
Nancy Piper Jenks Ms CfnpTreasurer0.5$0
Kemi Alli MdDirector0.5$0
Victoria VallejoDirector0.5$0
Sara Palomino Dnp Rn FnpChair0.5$0
Rebecca Collins Do MphDirector0.5$0
Avi Silber MdDirector0.5$0
Dolores Cottrell Dds MshaSecretary0.5$0
Daren Wu MdPast Chair0.5$0
Lois Bookhardt-MurrayDirector0.5$0

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202032749349300928_public.xml